L S Welage

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi request reprint Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases
    L S Welage
    College of Pharmacy, University of Michigan, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 40:52-62; quiz 121-3. 2000
  2. ncbi request reprint Pharmacologic features of proton pump inhibitors and their potential relevance to clinical practice
    Lynda S Welage
    Department of Clinical Sciences, University of Michigan, College of Pharmacy, Department of Pharmacy Services, Michigan University Medical Center, Ann Arbor, MI, USA
    Gastroenterol Clin North Am 32:S25-35. 2003
  3. ncbi request reprint Overview of pharmacologic agents for acid suppression in critically ill patients
    Lynda S Welage
    The University of Michigan, College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109 1065, USA
    Am J Health Syst Pharm 62:S4-S10. 2005
  4. ncbi request reprint Pharmacologic properties of proton pump inhibitors
    Lynda S Welage
    Department of Clinical Sciences, University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109, USA
    Pharmacotherapy 23:74S-80S. 2003
  5. ncbi request reprint Understanding the scientific issues embedded in the generic drug approval process
    L S Welage
    Department of Clinical Sciences, College of Pharmacy, University of Michigan Health System, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 41:856-67. 2001
  6. ncbi request reprint Historical overview of generic medication policy
    F J Ascione
    College of Pharmacy, University of Michigan, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 41:567-77. 2001
  7. ncbi request reprint Economics and structure of the generic pharmaceutical industry
    D M Kirking
    Department of Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 41:578-84. 2001
  8. ncbi request reprint Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration
    N A Mason
    College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109 1065, USA
    Clin Nephrol 60:96-104. 2003
  9. pmc Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine
    Stephen M Stout
    University of Michigan College of Pharmacy, 428 Church St, Ann Arbor, MI 48109 1065, USA
    J Clin Pharmacol 51:389-96. 2011
  10. ncbi request reprint Drug product selection: legal issues
    T P Christensen
    College of Pharmacy, North Dakota State University, Fargo 58105, USA
    J Am Pharm Assoc (Wash) 41:868-74. 2001

Collaborators

  • F J Ascione
  • D M Kirking
  • Gordon L Amidon
  • T P Christensen
  • N A Mason
  • R D Swartz
  • J W Devlin
  • K M Olsen
  • Stephen M Stout
  • Cesar Alaniz
  • Kazutaka Higaki
  • Ryan J Daley
  • Christopher P Landowski
  • Jeffrey L Barnett
  • Chandrasekharan Ramachandran
  • Narushi Takamatsu
  • Michael Shea
  • Jace Nielsen
  • Barry E Bleske
  • Kevin Kerber
  • Robert Brook
  • Rima A Mohammad
  • Raimar Lobenberg
  • Sally Y Choe
  • Jill A Rebuck
  • Frederick B Rogers
  • David R Foster
  • Sujatha S Menon
  • Duxin Sun
  • Lawrence J Lesko
  • Ryuzo Yamamoto
  • Vinod P Shah
  • Yayoi Hayashi

Detail Information

Publications18

  1. ncbi request reprint Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases
    L S Welage
    College of Pharmacy, University of Michigan, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 40:52-62; quiz 121-3. 2000
    ..To review the comparative efficacy and safety of the proton pump inhibitors (PPIs)--omeprazole, lansoprazole, pantoprazole, and rabeprazole--in the management of acid-related diseases...
  2. ncbi request reprint Pharmacologic features of proton pump inhibitors and their potential relevance to clinical practice
    Lynda S Welage
    Department of Clinical Sciences, University of Michigan, College of Pharmacy, Department of Pharmacy Services, Michigan University Medical Center, Ann Arbor, MI, USA
    Gastroenterol Clin North Am 32:S25-35. 2003
    ..PK/PD principles can be used to optimize PPI therapy when considering issues related to administration, such as timing of drug delivery relative to the number of active pumps and the drug's AUC...
  3. ncbi request reprint Overview of pharmacologic agents for acid suppression in critically ill patients
    Lynda S Welage
    The University of Michigan, College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109 1065, USA
    Am J Health Syst Pharm 62:S4-S10. 2005
    ....
  4. ncbi request reprint Pharmacologic properties of proton pump inhibitors
    Lynda S Welage
    Department of Clinical Sciences, University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109, USA
    Pharmacotherapy 23:74S-80S. 2003
    ..Although they share a common core structure and mechanism of action, it is important to understand the general pharmacology of these agents and how they differ from histamine2-receptor antagonists in order to optimize PPI therapy...
  5. ncbi request reprint Understanding the scientific issues embedded in the generic drug approval process
    L S Welage
    Department of Clinical Sciences, College of Pharmacy, University of Michigan Health System, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 41:856-67. 2001
    ..To review the major scientific issues embedded in the generic drug approval process...
  6. ncbi request reprint Historical overview of generic medication policy
    F J Ascione
    College of Pharmacy, University of Michigan, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 41:567-77. 2001
    ..To provide a historical perspective on controversies surrounding the use of generic drugs...
  7. ncbi request reprint Economics and structure of the generic pharmaceutical industry
    D M Kirking
    Department of Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor 48109 1065, USA
    J Am Pharm Assoc (Wash) 41:578-84. 2001
    ..To review key economic trends of the generic medication market and analyze the changing structure of the generic medication industry...
  8. ncbi request reprint Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration
    N A Mason
    College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109 1065, USA
    Clin Nephrol 60:96-104. 2003
    ..Specifically, this study was designed to compare the pharmacokinetics of vancomycin when administered during the last 1-2 hours of dialysis (i.e. intra-dialytic administration) to that administered after completion of dialysis...
  9. pmc Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine
    Stephen M Stout
    University of Michigan College of Pharmacy, 428 Church St, Ann Arbor, MI 48109 1065, USA
    J Clin Pharmacol 51:389-96. 2011
    ..This could theoretically result in greater beta-blockade and lost cardioselectivity. The magnitude of the interaction was similar between metoprolol formulations, which may be attributable to low doses/drug input rates employed...
  10. ncbi request reprint Drug product selection: legal issues
    T P Christensen
    College of Pharmacy, North Dakota State University, Fargo 58105, USA
    J Am Pharm Assoc (Wash) 41:868-74. 2001
    ..To review the potential legal liability of the pharmacist in the drug product selection process...
  11. ncbi request reprint Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters
    Christopher P Landowski
    College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 1065, USA
    J Pharmacol Exp Ther 306:778-86. 2003
    ....
  12. doi request reprint Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humans
    Kazutaka Higaki
    College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109, USA
    Eur J Pharm Biopharm 70:313-25. 2008
    ..Further, estimates of k(a) derived using the time-dependent absorption model were closer to the intrinsic absorption rate constant for caffeine...
  13. doi request reprint Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage
    Cesar Alaniz
    Department of Pharmacy Services, College of Pharmacy, University of Michigan Hospitals and Health Centers, Ann Arbor, Michigan 48109, USA
    Pharmacotherapy 29:248-54. 2009
    ..To assess the effect of a prolonged continuous infusion of pantoprazole on patient outcomes when the drug was combined with standard octreotide therapy in patients with variceal hemorrhage...
  14. ncbi request reprint Proton pump inhibitor formulary considerations in the acutely ill. Part 1: Pharmacology, pharmacodynamics, and available formulations
    John W Devlin
    School of Pharmacy, Northeastern University, Boston, MA 02115 5000, USA
    Ann Pharmacother 39:1667-77. 2005
    ....
  15. ncbi request reprint Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics
    John W Devlin
    School of Pharmacy, Northeastern University Medical Intensive Care Unit, Tufts New England Medical Center, Boston, MA 02115 5000, USA
    Ann Pharmacother 39:1844-51. 2005
    ....
  16. ncbi request reprint Prevention of stress ulceration: current trends in critical care
    Ryan J Daley
    Pharmacotherapy Department, Fletcher Allen Health Care, Burlington, VT, USA
    Crit Care Med 32:2008-13. 2004
    ....
  17. ncbi request reprint The cost-effectiveness of proton pump inhibitors for bleeding peptic ulcers: The unanswered questions
    John W Devlin
    Crit Care Med 32:1415-6. 2004
  18. ncbi request reprint Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motility
    Narushi Takamatsu
    Yamanouchi Pharmaceutical Co Ltd, Shizuoka, Japan
    Eur J Pharm Biopharm 53:37-47. 2002
    ....